Izradite svoj profil
Citirano
Sve | Od 2019. | |
---|---|---|
Citati | 5088 | 1376 |
H-indeks | 31 | 20 |
i10-indeks | 38 | 27 |
Javni pristup
Prikaži sve1 članak
2 članka
dostupno
nije dostupno
Na temelju uvjeta financiranja
Suautori
- Andrei LupasDirector of the Department of Protein Evolution, Max-Planck-Institute for BiologyPotvrđena adresa e-pošte na tuebingen.mpg.de
- James R BrownSelf-employedPotvrđena adresa e-pošte na drexel.edu
- Peter G. WolynesBullard-Welch Foundation Professor of Science, Professor of Chemistry, Professor of PhysicsPotvrđena adresa e-pošte na rice.edu
- Benjamin BaxResearch FellowPotvrđena adresa e-pošte na cardiff.ac.uk
- Zaida (Zan) Luthey-SchultenUniversity of Illinois at Urbana-ChampaignPotvrđena adresa e-pošte na illinois.edu
- Roiban Gheorghe-DoruGlaxoSmithKline plcPotvrđena adresa e-pošte na gsk.com
- Chaya DuraiswamiProduct Director (Safety & Efficacy), GlaxosmithklinePotvrđena adresa e-pošte na gsk.com
- Sergej DjuranovicProfessor of Cell Biology and Physiology, Washington UniversityPotvrđena adresa e-pošte na wustl.edu
- Rob RussellProfessor of Protein Evolution, BioQuant/BZH, Heidelberg University, GermanyPotvrđena adresa e-pošte na bioquant.uni-heidelberg.de
- Peter GoughInzen TherapeuticsPotvrđena adresa e-pošte na inzentx.com
- John D LichPharmaPotvrđena adresa e-pošte na gsk.com
- John BertinSanofiPotvrđena adresa e-pošte na sanofi.com
- Vikram AlvaMax Planck Institute for BiologyPotvrđena adresa e-pošte na tuebingen.mpg.de
- Philippe SanseauGSKPotvrđena adresa e-pošte na gsk.com
- Markus GruberNokia Bell LabsPotvrđena adresa e-pošte na nokia.com
- Peter TumminoChief Scientific Officer, Nimbus TherapeuticsPotvrđena adresa e-pošte na nimbustx.com
- Robert A. CopelandPresident & CSO, Accent Therapeutics, Inc.Potvrđena adresa e-pošte na accenttx.com